MGTX

Meiragtx Holdings Plc

• Seeking Alpha·10/14 14:37

  MeiraGTx: The Data Held Up, The Valuation Didn't (Rating Downgrade)

• Simply Wall St·10/12 17:22

  MeiraGTx Holdings (MGTX) Pulls Back On Valuation Focus, Is The Stock Still Cheap?

• TipRanks·09/25 06:35

  MeiraGTx: Promising Gene Therapy Platform but Early-Stage Risks Keep Risk/Reward Balanced at Hold

• Simply Wall St·09/24 23:26

  MeiraGTx (MGTX) Stock Could Look Stretched As Earnings Face Questions

• Dow Jones·09/24 14:04

  MeiraGTx Holdings Price Target Announced at $16.00/Share by Goldman Sachs

• Benzinga·09/24 13:54

  Goldman Sachs Initiates Coverage On MeiraGTx Holdings with Neutral Rating, Announces Price Target of $16

• TipRanks·09/24 08:45

  MeiraGTx initiated with a Neutral at Goldman Sachs

• TipRanks·09/23 12:28

  MeiraGTx Appoints Veteran Investor Alan Sebulsky to Board

• TipRanks·09/23 12:26

  MeiraGTx appoints Sebulsky to its Board of Directors

• Dow Jones·09/23 12:01

  Press Release: MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors

• Simply Wall St·09/04 07:33

  MeiraGTx Holdings (MGTX) Has Rallied Sharply, Is The Current P/E Too Expensive?

• PR Newswire·08/26 14:49

  Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical

• Simply Wall St·08/25 08:21

  Why MeiraGTx (MGTX) Is Up 7.7% After Swing to Q2 Profitability and New Leadership Hires

• Simply Wall St·08/18 06:26

  MeiraGTx Holdings (MGTX) Earnings Turnaround Puts Its Valuation Back In Focus

• TipRanks·08/17 12:21

  Piper Sandler Sticks to Their Buy Rating for Meiragtx Holdings (MGTX)